Related references
Note: Only part of the references are listed.Clostridium difficile infection in Europe: a hospital-based survey
Martijn P. Bauer et al.
LANCET (2011)
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden
T. Noren et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Clostridium difficile Isolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018
Patrizia Spigaglia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas
Z-D Jiang et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary
Gabriella Terhes et al.
ANAEROBE (2009)
High Frequency of Rifampin Resistance Identified in an Epidemic Clostridium difficile Clone from a Large Teaching Hospital
Scott R. Curry et al.
CLINICAL INFECTIOUS DISEASES (2009)
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm
H. Huang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Correlation of Multidrug Resistance, Toxinotypes and PCR Ribotypes in Clostridium difficile Isolates from Kuwait
W. Y. Jamal et al.
JOURNAL OF CHEMOTHERAPY (2009)
Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea
Kevin W. Garey et al.
ANNALS OF PHARMACOTHERAPY (2008)
Rifampin and rifaximin resistance in clinical isolates of Clostfdium diicile
Jennifer R. O'Connor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Metronidazole resistance in Clostridium difficile is heterogeneous
T. Pelaez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe
Patrizia Spigaglia et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
New antimicrobial agents for patients with Clostridium difficile infections
John G. Bartlett
Current Infectious Disease Reports (2008)
Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile
Patrizia Spigaglia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Clindamycin-resistant clone of Clostridium difficile PCR ribotype 027, Europe
Denise Drudy et al.
EMERGING INFECTIOUS DISEASES (2008)
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates
F. Barbut et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile
Christoph Schmidt et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland
Hanna Pituch et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Distribution of specific tetracycline and erythromycin resistance genes in environmental samples assessed by macroarray detection
Andrea J. Patterson et al.
ENVIRONMENTAL MICROBIOLOGY (2007)
Moxifloxacin therapy as a risk factor for clostridium difficile-associated disease during an outbreak: Attempts to control a new epidemic strain
Priscilla Biller et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027
Denise Drudy et al.
EMERGING INFECTIOUS DISEASES (2007)
The mosaic nature of intergenic 16S-23S rRNA spacer regions suggests rRNA operon copy number variation in Clostridium difficile strains
Nourkhoda Sadeghifard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in southern Quebec, Canada
Anne-Marie Bourgault et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
New variants of the tet(M) gene in Clostridium difficile clinical isolates harbouring Tn916-like elements
Patrizia Spigaglia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance
H Pituch et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
ErmB determinants and Tn916-like elements in clinical isolates of Clostridium difficile
P Spigaglia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A large outbreak of Clostridium Difficile -: Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use
CA Muto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Outbreak of Clostridium difficile infection in a long-term care facility:: Association with gatifloxacin use
R Gaynes et al.
CLINICAL INFECTIOUS DISEASES (2004)
Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods
P Spigaglia et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile
G Ackermann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The role of conjugative transposons in spreading antibiotic resistance between bacteria that inhabit the gastrointestinal tract
KP Scott
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin
T Peláez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Widespread distribution of a tet W determinant among tetracycline-resistant isolates of the animal pathogen Arcanobacterium pyogenes
SJ Billington et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antibiotic-associated diarrhea
JG Bartlett
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Reduced susceptibility of Clostridium difficile to metronidazole
JS Brazier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile
KA Farrow et al.
MICROBIOLOGY-SGM (2001)
Comparison of Tn5397 from Clostridium difficile, Tn916 from Enterococcus faecalis and the CW459tet(M) element from Clostridium perfringens shows that they have similar conjugation regions but different insertion and excision modules
AP Roberts et al.
MICROBIOLOGY-SGM (2001)
Macrolide resistance conferred by base substitutions in 23S rRNA
B Vester et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Transposition of Tn4451 and Tn4453 involves a circular intermediate that forms a promoter for the large resolvase, TnpX
D Lyras et al.
MOLECULAR MICROBIOLOGY (2000)
In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species
A Marchese et al.
CHEMOTHERAPY (2000)
The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes
KA Farrow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
